Jones, S. K. and Merkel, O. M.
(2016):
Tackling breast cancer chemoresistance with nano-formulated siRNA.
In: Gene therapy, Vol. 23, No. 12: pp. 821-828
DOI: 10.1038/gt.2016.67
Abstract
Breast cancer is the leading cancer diagnosed in women and the second leading cause of cancer-related deaths in women. Current limitations to standard chemotherapy in the clinic are extensively researched, including problems arising from repeated treatments with the same drugs. The phenomenon that cancer cells become resistant toward certain chemo drugs is called chemotherapy resistance. In this review, we are focusing on nanoformulation of siRNA for the fight against breast cancer chemoresistance.
| Item Type: | Journal article |
|---|---|
| Faculties: | Chemistry and Pharmacy > Department of Pharmacy |
| Subjects: | 500 Science > 540 Chemistry |
| ISSN: | 0969-7128 |
| Language: | English |
| Item ID: | 48463 |
| Date Deposited: | 27. Apr 2018, 08:15 |
| Last Modified: | 10. May 2022, 05:38 |
Actions (login required)
- View Item
